vialauditThe Roundup
KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02

Bio Elevate: 6 Kovera certificates.

The lab's record shows 6 certificates printed for Bio Elevate, analysed between 16 Feb 2026 and 27 Feb 2026, covering 6 products. Median HPLC purity is 99.96%. Kovera graded 6 as a pass and 0 as a fail.

6
certificates
99.96%
median purity
6
products
0
lab verdict: fail
0
failure rules met

What the record shows

RETRIEVED 2 AUGUST 2026

None of the 6 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 4 measured more than 110% of the label, which Kovera does not grade as a fail.

A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.

Products tested

6 AS PRINTED
CJC-1295 (No DAC)/Ipamorelin · 1DSIP · 1Glutathion · 1Klow · 1MOTS-c · 1Semax · 1

Every certificate

NEWEST FIRST · 6 ROWS
ReportProductLotPurity% of labelAnalysedResultCheck
KVR-2026-49D864DSIPDSP000193399.961%118.4%11.84 of 10 mg27 Feb 2026PASSover 110% of labelKovera ↗our verifier →
KVR-2026-1177E6GlutathionGTA00035499.933%97.0%1454.61 of 1500 mg27 Feb 2026PASSKovera ↗our verifier →
KVR-2026-0AEEB3SemaxSX000709599.972%124.9%12.49 of 10 mg27 Feb 2026PASSover 110% of labelKovera ↗our verifier →
KVR-2026-A87BAAKlowKLW000116199.96%113.4%90.71 of 80 mg19 Feb 2026PASSover 110% of labelKovera ↗our verifier →
KVR-2026-8EF434MOTS-cMC00091799.96%106.6%10.66 of 10 mg16 Feb 2026PASSKovera ↗our verifier →
KVR-2026-66CE02CJC-1295 (No DAC)/IpamorelinCJC000142199.841%116.1%11.61 of 10 mg16 Feb 2026PASSover 110% of labelKovera ↗our verifier →

More from the index

ALL KOVERA CLIENTS →
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH